Fig. 2From: A controlled clinical study on efficacy and safety of periocular triamcinolone acetonide injection for treating ocular myasthenia gravisTypical case 2. a 22-year-old female patient with OMG who initially had mild ptosis and abduction in the right eye (Figure A). After four injections of triamcinolone acetonide per week, her symptoms were completely relieved (Figure B). The treatment was maintained for 3 months and then discontinued medication. Recurrence occurred 3 months after discontinuation, with ptosis of left eye (Figure C). The patient’s symptoms rapidly worsened, and developed supraduction and neck weakness. Diagnosis of mild GMG was made (Figure D). After re-injection of triamcinolone acetonide with the combination of oral administration of tacrolimus for 6 weeks, her symptoms recovered (Figure E) again. At present, MMS condition was maintained using medication. From top to bottom, Figure A, B, C, D, EBack to article page